Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Aug;80(8):745–749. doi: 10.1136/bjo.80.8.745

Analysis of 21 Stargardt's disease families confirms a major locus on chromosome 1p with evidence for non-allelic heterogeneity in a minority of cases.

B H Weber 1, S Sander 1, C Kopp 1, D Walker 1, A Eckstein 1, B Wissinger 1, E Zrenner 1, T Grimm 1
PMCID: PMC505593  PMID: 8949721

Abstract

BACKGROUND: Autosomal recessive Stargardt's disease is a macular degeneration characterised by a juvenile onset and a rapidly progressive course resulting in an atrophic macular area typically surrounded by yellowish retinal flecks. METHOD: The disease locus has previously been assigned to markers from chromosome 1p21-p13 by genetic linkage analysis in eight multiplex Stargardt's disease families. RESULTS: In an extended analysis, the assignment to chromosome 1p was confirmed in the majority of the 21 families with Stargardt's disease who were studied. In addition, a series of recombinant chromosomes further narrowed the Stargardt's disease region to an approximately 3 cM interval between markers at D1S424 and D1S497. CONCLUSION: Multipoint linkage analysis most probably excludes this locus in three of these families suggesting non-allelic heterogeneity with at least one additional minor Stargardt's disease locus.

Full text

PDF
745

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bither P. P., Berns L. A. Dominant inheritance of Stargardt's disease. J Am Optom Assoc. 1988 Feb;59(2):112–117. [PubMed] [Google Scholar]
  2. Bowcock A., Osborne-Lawrence S., Barnes R., Weiss L., Dunn G. Dinucleotide repeat polymorphism at the D1S167 locus. Hum Mol Genet. 1992 May;1(2):138–138. doi: 10.1093/hmg/1.2.138. [DOI] [PubMed] [Google Scholar]
  3. Buetow K. H., Weber J. L., Ludwigsen S., Scherpbier-Heddema T., Duyk G. M., Sheffield V. C., Wang Z., Murray J. C. Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet. 1994 Apr;6(4):391–393. doi: 10.1038/ng0494-391. [DOI] [PubMed] [Google Scholar]
  4. Cibis G. W., Morey M., Harris D. J. Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol. 1980 Oct;98(10):1785–1789. doi: 10.1001/archopht.1980.01020040637010. [DOI] [PubMed] [Google Scholar]
  5. Dracopoli N. C., Meisler M. H. Mapping the human amylase gene cluster on the proximal short arm of chromosome 1 using a highly informative (CA)n repeat. Genomics. 1990 May;7(1):97–102. doi: 10.1016/0888-7543(90)90523-w. [DOI] [PubMed] [Google Scholar]
  6. Gerber S., Rozet J. M., Bonneau D., Souied E., Weissenbach J., Frezal J., Munnich A., Kaplan J. Exclusion of the cone-specific alpha-subunit of the transducin gene in Stargardt's disease. Hum Genet. 1995 Apr;95(4):382–384. doi: 10.1007/BF00208959. [DOI] [PubMed] [Google Scholar]
  7. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  8. Kaplan J., Bonneau D., Frézal J., Munnich A., Dufier J. L. Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet. 1990 Oct;85(6):635–642. doi: 10.1007/BF00193589. [DOI] [PubMed] [Google Scholar]
  9. Kaplan J., Gerber S., Larget-Piet D., Rozet J. M., Dollfus H., Dufier J. L., Odent S., Postel-Vinay A., Janin N., Briard M. L. A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet. 1993 Nov;5(3):308–311. doi: 10.1038/ng1193-308. [DOI] [PubMed] [Google Scholar]
  10. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet. 1985 May;37(3):482–498. [PMC free article] [PubMed] [Google Scholar]
  11. Mansour A. M. Long-term follow-up of dominant macular dystrophy with flecks (Stargardt). Ophthalmologica. 1992;205(3):138–143. doi: 10.1159/000310329. [DOI] [PubMed] [Google Scholar]
  12. Matise T. C., Perlin M., Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet. 1994 Apr;6(4):384–390. doi: 10.1038/ng0494-384. [DOI] [PubMed] [Google Scholar]
  13. Noble K. G., Carr R. E. Stargardt's disease and fundus flavimaculatus. Arch Ophthalmol. 1979 Jul;97(7):1281–1285. doi: 10.1001/archopht.1979.01020020023005. [DOI] [PubMed] [Google Scholar]
  14. Santavuori P., Haltia M., Rapola J., Raitta C. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci. 1973 Mar;18(3):257–267. doi: 10.1016/0022-510x(73)90075-0. [DOI] [PubMed] [Google Scholar]
  15. Stone E. M., Nichols B. E., Kimura A. E., Weingeist T. A., Drack A., Sheffield V. C. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol. 1994 Jun;112(6):765–772. doi: 10.1001/archopht.1994.01090180063036. [DOI] [PubMed] [Google Scholar]
  16. Vesa J., Hellsten E., Verkruyse L. A., Camp L. A., Rapola J., Santavuori P., Hofmann S. L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 1995 Aug 17;376(6541):584–587. doi: 10.1038/376584a0. [DOI] [PubMed] [Google Scholar]
  17. Wisneiwski K. E., Kida E., Patxot O. F., Connell F. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations. Am J Med Genet. 1992 Feb 15;42(4):525–532. doi: 10.1002/ajmg.1320420420. [DOI] [PubMed] [Google Scholar]
  18. Zhang K., Bither P. P., Park R., Donoso L. A., Seidman J. G., Seidman C. E. A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol. 1994 Jun;112(6):759–764. doi: 10.1001/archopht.1994.01090180057035. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES